Drugs / Qing Re Huo Xue
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT04170504 | Nov 2019 → Jun 2022 | rheumatoid arthritis | Guang'anmen Hospital of China Academy of Chinese Medical Sciences | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Qing Re Huo Xue | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04170504 ↗ |
| Known as | QRHX | “The aim of the study is to evaluate whether Chinese herbal medicine Qing Re Huo Xue (QRHX) combined with methotrexate (MTX) might be better than Qing Re Huo Xue placebo...” NCT04170504 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Chinese herbal medicine Qing Re Huo Xue (QRHX)” NCT04170504 ↗ |